Organization
Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China
3 abstracts
Abstract
Phase Ib/IIa safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced solid tumors.Org: Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Renal Cancer and Melanoma, Peking University Cancer Hospital & Institute, Beijing, China, Department of Oncology, Jilin Cancer Hospital, Changchun, China, Linyi Cancer Hospital, Linyi, China, Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China,
Abstract
SI-B003 (PD-1/CTLA-4) in patients with advanced solid tumors: A phase I study.Org: Department of Early Drug Development Center, Peking University Cancer Hospital & Institute, Beijing, China, Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China, Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China, Henan Cancer Hospital, Zhengzhou, China, Shanghai General Hospital, Shanghai, China,
Abstract
Efficacy and safety of SY-3505, a third-generation ALK TKI, in ALK-positive advanced non-small cell lung cancer: Results from a phase I/II, multi-center study.Org: Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing Key Laboratory of Clinical Study On Anticancer Molecular Targeted Drugs, Beijing, China, Department of Medical Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, Department of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China, Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, China, Department of Respiratory and Critical Care Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China,